Literature DB >> 23135711

Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication.

Coral K Wille1, Dhananjay M Nawandar, Amanda R Panfil, Michelle M Ko, Stacy R Hagemeier, Shannon C Kenney.   

Abstract

The Epstein-Barr virus (EBV) immediate-early proteins BZLF1 and BRLF1 can both induce lytic EBV reactivation when overexpressed in latently infected cells. Although EBV genome methylation is required for BZLF1-mediated activation of lytic gene expression, the effect of viral genome methylation on BRLF1-mediated viral reactivation has not been well studied. Here, we have compared the effect of viral DNA methylation on BZLF1- versus BRLF1-mediated activation of lytic EBV gene transcription and viral genome replication. We show that most early lytic viral promoters are preferentially activated by BZLF1 in the methylated form, while methylation decreases the ability of BRLF1 to activate most early lytic promoters, as well as the BLRF2 late viral promoter. Moreover, methylation of bacmid constructs containing the EBV genome enhances BZLF1-mediated, but decreases BRLF1-mediated, early lytic gene expression. Methylation of viral promoter DNA does not affect BRLF1 binding to a variety of different CpG-containing BRLF1 binding motifs (RREs) in vitro or in vivo. However, BRLF1 preferentially induces H3K9 histone acetylation of unmethylated promoters in vivo. The methylated and unmethylated forms of an oriLyt-containing plasmid replicate with similar efficiency when transfected into EBV-positive cells that express the essential viral replication proteins in trans. Most importantly, we demonstrate that lytic viral gene expression and replication can be induced by BRLF1, but not BZLF1, expression in an EBV-positive telomerase-immortalized epithelial cell line (NOKs-Akata) in which lytic viral gene promoters remain largely unmethylated. These results suggest that the unmethylated form of the EBV genome can undergo viral reactivation and replication in a BRLF1-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23135711      PMCID: PMC3554042          DOI: 10.1128/JVI.01790-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites.

Authors:  T Ragoczy; G Miller
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Epstein-Barr virus infection and replication in a human epithelial cell system.

Authors:  Q X Li; L S Young; G Niedobitek; C W Dawson; M Birkenbach; F Wang; A B Rickinson
Journal:  Nature       Date:  1992-03-26       Impact factor: 49.962

3.  AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome.

Authors:  Markus Kalla; Anne Schmeinck; Martin Bergbauer; Dagmar Pich; Wolfgang Hammerschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

4.  Evidence for coiled-coil dimer formation by an Epstein-Barr virus transactivator that lacks a heptad repeat of leucine residues.

Authors:  E Flemington; S H Speck
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

5.  A replication function associated with the activation domain of the Epstein-Barr virus Zta transactivator.

Authors:  R T Sarisky; Z Gao; P M Lieberman; E D Fixman; G S Hayward; S D Hayward
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

6.  Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion.

Authors:  J S Greenspan; D Greenspan; E T Lennette; D I Abrams; M A Conant; V Petersen; U K Freese
Journal:  N Engl J Med       Date:  1985-12-19       Impact factor: 91.245

7.  Genome-wide analysis of Epstein-Barr virus Rta DNA binding.

Authors:  Andreas M F Heilmann; Michael A Calderwood; Daniel Portal; Yong Lu; Eric Johannsen
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

8.  An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators.

Authors:  M A Cox; J Leahy; J M Hardwick
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

9.  Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism.

Authors:  S Zalani; E Holley-Guthrie; S Kenney
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

10.  Epigenetic control of viral life-cycle by a DNA-methylation dependent transcription factor.

Authors:  Kirsty Flower; David Thomas; James Heather; Sharada Ramasubramanyan; Susan Jones; Alison J Sinclair
Journal:  PLoS One       Date:  2011-10-11       Impact factor: 3.240

View more
  34 in total

1.  Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region.

Authors:  Aron R Marquitz; Anuja Mathur; Rachel Hood Edwards; Nancy Raab-Traub
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

2.  Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes.

Authors:  Yen-Ju Chen; Yu-Lian Chen; Yao Chang; Chung-Chun Wu; Ying-Chieh Ko; Sai Wah Tsao; Jen-Yang Chen; Su-Fang Lin
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

Review 3.  The Long and Complicated Relationship between Epstein-Barr Virus and Epithelial Cells.

Authors:  Lindsey M Hutt-Fletcher
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

4.  The B-cell-specific transcription factor and master regulator Pax5 promotes Epstein-Barr virus latency by negatively regulating the viral immediate early protein BZLF1.

Authors:  Ryan M Raver; Amanda R Panfil; Stacy R Hagemeier; Shannon C Kenney
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

Review 5.  Regulation of the latent-lytic switch in Epstein-Barr virus.

Authors:  Shannon C Kenney; Janet E Mertz
Journal:  Semin Cancer Biol       Date:  2014-01-20       Impact factor: 15.707

6.  Genipin as a novel chemical activator of EBV lytic cycle.

Authors:  Myoungki Son; Minjung Lee; Eunhyun Ryu; Aree Moon; Choon-Sik Jeong; Yong Woo Jung; Gyu Hwan Park; Gi-Ho Sung; Hyosun Cho; Hyojeung Kang
Journal:  J Microbiol       Date:  2015-01-28       Impact factor: 3.422

Review 7.  Epstein-Barr virus: a master epigenetic manipulator.

Authors:  Rona S Scott
Journal:  Curr Opin Virol       Date:  2017-08-04       Impact factor: 7.090

8.  Epstein-Barr virus utilizes Ikaros in regulating its latent-lytic switch in B cells.

Authors:  Tawin Iempridee; Jessica A Reusch; Andrew Riching; Eric C Johannsen; Sinisa Dovat; Shannon C Kenney; Janet E Mertz
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

9.  Differential cellular localization of Epstein-Barr virus and human cytomegalovirus in the colonic mucosa of patients with active or quiescent inflammatory bowel disease.

Authors:  Rachele Ciccocioppo; Francesca Racca; Luigia Scudeller; Antonio Piralla; Pietro Formagnana; Lodovica Pozzi; Elena Betti; Alessandro Vanoli; Roberta Riboni; Peter Kruzliak; Fausto Baldanti; Gino Roberto Corazza
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

Review 10.  Keeping it quiet: chromatin control of gammaherpesvirus latency.

Authors:  Paul M Lieberman
Journal:  Nat Rev Microbiol       Date:  2013-11-06       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.